A study of 118 observational studies, based upon around a million patients with a wide range of cancers, finds that taking a daily low-dose (75 or 81 mg/day) of aspirin was associated with a 20% reduction in deaths from cancer and in deaths from all causes

A study of 118 observational studies, based upon around a million patients with a wide range of cancers, finds that taking a daily low-dose (75 or 81 mg/day) of aspirin was associated with a 20% reduction in deaths from cancer and in deaths from all causes